Snowball logo
logo
4512_logo

Wakamoto Pharmaceutical Co Ltd

4512 TSE
¥270.00¥0.00  (0%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20222023202420252026TTM
Revenue
Total revenue
8,383.18,660.47,738.47,789.59,906.810,163.8
COGS
4,027.34,552.34,197.64,1675,176.45,501.8
Gross Profit
4,355.94,108.13,540.83,622.54,730.54,662
Operating Expenses & Income
Operating Income
(13.39)141.5(195.5)(457.8)255.5262.5
Total Operating Expenses
4,369.33,966.63,736.44,080.34,474.94,399.5
R&D Expenses
594580.5513.3419.1--
Selling General & Admin Expenses
4,369.33,326.8----
Earnings from Continuing Operations
Interest Expense
(0.575)(0.578)(0.531)(0.882)(1.895)(3.353)
Interest Income
257.30.0280.0291.4312.586-
Income Tax Expense
46.3173.3249.9(56.98)29.1876.81
Net Income
Net Income
238.5138.310964.44227.2342.4
Supplemental
EBIT
285.4212.2159.48.339258.3239.1
EBITDA
755.5575.8504.8438.7701.2702.8
In millions of JPY, except % and values per 1 share